Conditions: Prostate Cancer
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 126
Healthy volunteers: no

Brief summary:
Assess the efficacy and safety of Triptorelin pamoate 3M formulation (11.25mg) when administered by subcutaneous route.

Detailed description:

Arms:
arm 1: 11.25mg, SC on Day 1 and Day 92

Interventions: intervention 1: Triptorelin Pamoate 11.25mg
Intervention descriptions: intervention 1: None

Protocol document: